Clinical trials, adaptability and the COVID-19 pandemic | Zendy

Ramez N. Eskander | Zendy; Bhavana Pothuri | Zendy; Leslie M. Randall | Zendy; David M. O’Malley | Zendy; Brian M. Slomovitz | Zendy; Kathleen N. Moore | Zendy; Robert L. Coleman | Zendy; Thomas J. Herzog | Zendy; Bradley J. Monk | Zendy; Larry J. Copeland | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical trials, adaptability and the COVID-19 pandemic

Author(s) -

Ramez N. Eskander,

Bhavana Pothuri,

Leslie M. Randall,

David M. O’Malley,

Brian M. Slomovitz,

Kathleen N. Moore,

Robert L. Coleman,

Thomas J. Herzog,

Bradley J. Monk,

Larry J. Copeland

Publication year - 2020

Publication title -

gynecologic oncology reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.557

H-Index - 15

ISSN - 2352-5789

DOI - 10.1016/j.gore.2020.100680

Subject(s) - pandemic , medicine , covid-19 , clinical trial , adaptability , public health , foundation (evidence) , intensive care medicine , medical emergency , virology , nursing , disease , pathology , outbreak , political science , management , law , economics , infectious disease (medical specialty)

Highlights • The COVID-19 pandemic has required adaptability in the workplace.• Women health care professionals are disproportionately affected by the burdens resulting from the pandemic.• Flexible work options are critical to ensure staff have the resources to provide cancer care and clinical trial options.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research